
Nemaura Makes “The Announcement”
In a press release this morning, Nemaura Medical (NMRD), a medical technology company focused on diabetes, announced receipt of a material purchase order from its U.K. licensee, DB Ethitronix Ltd. The press release describes the order as being for for 5,000 sugarBEAT® transmitters and 200,000 sugarBEAT® sensors, with an additional rolling monthly purchase order that […]